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Incision in the Treatment of Peyronie’s Disease
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ABSTRACT
Objective: Report the results using porcine small intestinal submucosa (SIS) as a graft material in the surgical management
of Peyronie’s disease (PD).
Materials and Methods: We performed a retrospective chart review of men with PD who underwent surgical correction
of the curvature by plaque “H” incision and patch grafting with 4-ply SIS (Cook, Bloomington, IN) by a single surgeon
at our institution. Degree and direction of curvature, sexual function, and co-morbidities were assessed pre- and postoperatively.
Results: Thirteen patients were identified. Mean age was 57 ±� ���
8, range
������ ������
42-70 ��������������
years. Median ��������������
follow-up was ���
14 ������
months,
range 3-89 months. At presentation, all reported penile curvature. Also reported were difficulty with vaginal penetration
(determined by question number 2 of the sexual encounter profile questionnaire – SEP2),
palpable plaque, hourglass deformity, difficulty with firmness, and difficulty with sustaining erection (determined by
SEP3) in77%, 69%, 77%, 62%, and 46% of patients, respectively. Mean and median degrees of curvature of the primary
deformity were 71 and 67.5 degrees, respectively. Three patients had secondary curves of less than 30 degrees in a different
direction. Mean and median plaque size were 3.5 and 2.7 cm2, respectively. Seven patients had one graft and six patients
had two grafts placed with a mean size of 15 ±
�� 0�� cm
��2.
Conclusions: For the patient with PD, SIS grafting can achieve a functionally straight erection with durable results yet
with relatively high rates of erectile dysfunction. SIS is a viable graft material for use in the surgical treatment of PD.
Key words: penis; Peyronie’s disease; surgery; graft; small intestinal submucosa
Int Braz J Urol. 2008; 34: 191-7

INTRODUCTION

deformity, and a later chronic phase in which the pain
ceases and the deformity is stabilized. Conservative
medical therapy is the initial treatment of choice for
patients with acute phase disease. A variety of medications has been utilized including vitamin E, paraaminobenzoate potassium, tamoxifen, colchicine, and
verapamil. In addition to oral therapy, intralesional

Peyronie’s disease (PD) is a condition of
plaque formation in the tunica albuginea of the corpora cavernosa with resultant curvature of the penis
(1). The disease has two phases; an early acute phase
associated with painful erections and progression of
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who underwent surgical correction of Peyronie’s
disease with plaque incision and patch grafting with
4-ply porcine small intestinal submucosa (Stratasis,
Cook Urological, Spencer, IN) at our institution by
a single surgeon between March 1999 and August
2006.
Thirteen patients were identified. Subjective
difficulty with vaginal penetration, firmness, and sustaining erection as well as age, erectile dysfunction,
use of pro-erectile medications, presence of palpable
plaque, plaque location, hourglass deformity, foreshortened penis, degree and direction of curvature,
flaccid and stretched penile length, and comorbidities (
hypertension, diabetes mellitus, Dupuytren’s contracture, plantar fasciitis, lower urinary tract symptoms)
were included in the preoperative analysis. Sexual
function was determined by SEP2.
Technique - The plaque incision and grafting
procedure was carried out as detailed in prior reports
(9). Briefly, subcoronal degloving incision was used
with subsequent degloving of the penis down to dartos fascia to expose the anterior lamella of Buck’s
fascia. The area of maximal curvature was identified
via artificial erection (Penrose tourniquet placement
at the base of the penis and continuous corporal infusion of sterile saline). The circumflex veins were
suture ligated or cauterized using bipolar current. If
the plaque was dorsally located, the neurovascular
bundle on the dorsal surface was mobilized under
loupe magnification down to the penoscrotal junction.
A relaxing incision was made in the plaque at the point
of maximum curvature in the shape of the letter “H”.
A graft of 4 layers SIS that was oversized to be 120%
of the size of the defect was hydrated in normal saline
and sewn in using 5-0 PDS running sutures. Assessment of curvature was repeated. Persistent curvature
was managed by a second H-incision and SIS graft or
by penile plication (by the 16-dot technique of Lue)
(6). The dartos was closed with a 3-0 vicryl suture and
the skin with 3-0 chromic followed by a compressive
Coban dressing for 48 hours.
Follow-up data was collected by the operating
surgeon at follow-up office visits. Postoperative penile
curvature, length, potency, use of erectile dysfunction
medications, pain, and palpable plaque were recorded.
Subjective (by patient) and objective (by physician)
cosmetic and functional outcomes were recorded.

injections and various forms of energy have been applied for the treatment of PD (2). Few medical therapies
have been proven effective in large scale trials. Surgical
correction is the treatment of choice when the deformity
precludes intercourse, but should not be considered
until the disease has reached its stable, chronic phase.
Surgical options for the management of PD
can be divided into 3 types: procedures that shorten
the convex, uninvolved side of the tunica albuginea,
procedures that lengthen the concave, diseased side,
and implantation of a penile prosthesis (3). Ellipsoid resection and closure of the tunica albuginea
on the healthy convex side, as first described by
Nesbit, was the previous standard for surgical care
(4). Subsequently, successful variations including a
Heineke-Mikulicz procedure and multiple parallel
plications have been reported (5,6). These procedures
are limited by a shorter postoperative penile length
that precludes their use in patients with large plaques,
severe deformities, or small penises (3). For these patients, superior results may be obtained using tunical
lengthening procedures where incision or excision
of the tunical plaque is followed by interposition of
a graft material to bridge the resulting defect in the
tunica. Plaque incision utilizing autologous materials
such as saphenous vein as patch grafts for the incised
defect has been reported to result in high rates of
patient satisfaction (7,8). Drawbacks to autologous
grafting are the increased morbidity of a secondary
tissue harvest site and increased OR time required for
tissue procurement and preparation.
Non-autologous “off the shelf” biomaterials
are an attractive alternative to autologous tissue for
patch grafting (3). At our institution we favor porcine
small intestinal submucosa (Stratasis, Cook Urological, Spencer, IN), a xenographic biomaterial retaining
matrix elements that support host cell migration and
differentiation. There have been some preliminary
reports describing the use of SIS in Peyronie’s disease
repair (9-12). We present our institution’s experience
with SIS grafts in 13 patients.

MATERIALS AND METHODS
Institutional review board approval was
obtained for a retrospective chart review of men
192
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RESULTS

Table 2 – Presenting symptoms.
Difficulty with vaginal penetration
Difficulty maintaining firmness
Difficulty sustaining erection
Potency (SEP 2/3)
Without ED medication
With ED medications
Not potent

Patient demographics are shown in Table-1.
Mean age was 57 ± 8 years (range = 42-70 years). The
median length of follow-up was 14 months (range 389 months). Table-2 lists presenting symptoms and
sexual function. Ten patients (77%) presented with
difficulty invaginal penetration (as determined by
the sexual encounter profile question 2 [SEP2]), 8
patients (62%) had difficulty maintaining firmness,
and 6 patients (46%) had difficulty sustaining erection (as determined by the sexual encounter profile
question 3 [SEP3]). Pre-operatively, 5 patients (38%)
were potent, 7 patients (54%) were potent with phosphodiesterase-5 inhibitors, and 1 (8%) was impotent,
as determined by SEP 2 and 3.
The plaque was palpable in 9 patients (69%),
and 10 patients (77%) had hourglass deformity. Penile
curvature was dorsal in 8 patients (62%), ventral in 2

57 ± 8
14
08
02
03
03
71
68
02
09
02
3.5
2.7
09
10
7
06
15 ± 10
11

0 5 (38%)
0 7 (54%)
0 1 (8%)0

ED = erectile dysfunction; SEP = sexual encounter profile
questionnaire.

patients (15%), and toward the left in 3 patients (23%).
Three patients (23%) had secondary curves of less
than 30 degrees in a different direction. The degree
of primary curvature ranged from 45 to 90 degrees,
with mean of 71 and median of 68. Nine plaques
(69%) were located in the mid-shaft, with 2 (15%) in
the proximal and 2 (15%) in the distal portion of the
phallus. Mean and median plaque size were 3.5 and
2.7 cm2, (range = 1 - 8) respectively.
At operation, 7 (54%) patients had one graft
and 6 (46%) patients had 2 grafts placed. Mean size
of graft was 15 ± 10 cm2 (range = 1.5 - 36). Eleven
patients (85%) required concomitant penile plication
for residual curvature.
Postoperative results are listed in Table-3. As
determined by combined stimulation test (intracaver-

Table 1 – Patient demographics.
Age (years)
Median follow-up (mo)
Characteristics of curvature
Dorsal
Ventral
Left
Secondary curve present
Mean degree curvature
Median degree curvature
Characteristics of plaque
Proximal
Mid-shaft
Distal
Mean size (cm2)
Median size (cm2)
Palpable plaque
Waist deformity
Number of grafts placed
1
2
Mean graft size (cm2)
Concomitant penile plication

10 (77%)
0 8 (62%)
0 6 (46%)

Range 42 - 70
%
(62)
(15)
(23)
(23)
range 45 - 90

Table 3 – Postoperative data.
Residual bend
None
Residual bend present
5 degree
10 degree
15 degree
Potency (SEP 2/3)
Without ED medication
With ED medications
Not potent
Waist deformity
Recurrent plaque

%
(15)
(69)
(15)
range 1 - 8
(69)
(77)
(54)
(46)
range 1.5 - 36
(85)

7 (54%)
6 (46%)
3 (23%)
1 (8%)0
2 (15%)
4 (31%)
2 (15%)
7 (54%)
2 (15%)
4 (30%)

ED = erectile dysfunction; SEP = sexual encounter profile
questionnaire.
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nosal injection of alprostadil), seven patients (54%)
had a completely straight phallus and six (46%) had
residual bends of less than 15 degrees (three 5 degree,
one 10 degree, two 15 degree). At follow-up, 4 patients (31%) were potent, 2 patients (15%) were potent
on medication, and 7 patients (54%) were impotent (as
determined by SEP 2 and 3). Two patients (15%) had
hourglass deformity and there was recurrent plaque
in 4 patients (30%).

and postoperatively, with one requiring intracavernous
injection therapy. In a later report at 20 months mean
follow-up with 97 patients, Knoll described only 6%
with residual curvature of less than ten degrees and
84% of patients retaining the same degree of potency
as preoperative with no penile shortening, pain, infection, hematoma, or bulging of graft site (16).
In our series of 13 patients, all deformities
were straightened either completely or with minimal
residual curvature. Our results are similar to Knoll,
being durable with no recurrent Peyronie’s disease
after 14 months median follow-up, although 4 patients (30%) had recurrent plaque and 2 (15%) had
residual hourglass deformity. No patients experienced
infection, bulging, or immunologic reaction at the
graft site. One patient had a hematoma at the surgical
site that resolved spontaneously without significant
sequelae.
John et al. published a case report series of 4
patients with less encouraging results, with 3 of their
4 patients suffering recurrent curvature; however, the
grafts used were oversized by only 10% rather than
20% (10). The single non-recurrence was only 20
degrees, with the others being 45, 80, and 90 degrees,
suggesting that the 10% oversizing may not have been
sufficient to compensate for graft contracture in the
more severe bends. Additionally, one recurrent bend
had been previously straightened with polytetrafluoroethylene mesh and another was grafted with 1-ply
rather than 4-ply SIS, making it difficult to draw
comparisons with our series.
Breyer et al. also reported a much higher
recurrence (37%) and complication rate (37%) using
SIS grafting in 19 PD patients after 15 months mean
follow-up (11). Their study used 1-ply rather than 4ply SIS, which may explain their higher recurrence
rate, as compared with our and Knoll’s series (9)
(both using 4-ply SIS). Also, many of Breyer’s complications were minor, including hematoma (26%)
and infection (5%). Furthermore, although 37% had
recurrent curvature, only one required subsequent
plication (5%). We feel that 1-ply SIS is too thin and
contracts more, and thus only 4-ply should be used
for PD grafting. Further study is clearly needed.
Most recently, Kovac and Brown compared
outcomes at 22 months mean follow-up after dermal,
pericardial, and SIS grafting for PD in a 36 patient

COMMENTS
Plaque incision and grafting is the procedure
of choice for the treatment of severe Peyronie’s disease. This precludes intercourse when patients have
large plaques, severe curvature, or a short phallus,
which makes the loss of penile length with plication
procedures unacceptable. Autologous grafts such as
saphenous vein have been used as patch grafts with
satisfactory results. However, non-autologous grafts
have the advantage of not requiring a second harvest
site, decreasing operative time and patient morbidity
as well as preserving graft material, such as saphenous
vein, should the patient require coronary artery bypass
surgery in the future.
SIS is an extracellular matrix that is 80 to 100
µm thick and composed of mainly Type I collagen.
The matrix retains angiogenic and other growth factors even after processing, and induces a rapid infiltration of native cells and neovascularization, acting
as a scaffold for cell differentiation and maturation
(13). A study using SIS in the fascia lata of dogs
demonstrated that as early as 6 weeks after grafting,
the SIS is completely replaced with a well vascularized connective tissue, a well organized collagen
framework and fiber orientation identical to that of the
original tissue (14). Furthermore, SIS grafting of the
tunica albuginea in rabbits has shown no significant
inflammatory response, corporeal fibrosis, or loss of
cavernous smooth muscle content (15).
Knoll first described the successful use of SIS
for the correction of Peyronie’s disease in 12 patients,
with good functional results and no complications
or patient complaints at 11 months mean follow-up
except for one recurrence requiring reoperation (9).
All patients achieved potency both preoperatively
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series (12). They reported better maintenance of
preoperative length and rigidity in patients with SIS
versus dermal or pericardial grafts as well as significant improvements in ED as determined by the
Sexual Health Inventory for Men (SHIM) score (17
postoperative vs. 10.1 preoperative). This is comparable with Knoll, who reported 84% maintenance of
potency, as well as Breyer, who reported no increase
in ED as determined by the SHIM score.
In contrast, patients in our series had a relatively high rate of postoperative erectile dysfunction
as determined by SEP 2 and 3. One patient was impotent preoperatively but a penile implant was not a
covered benefit of his insurance, and he underwent
grafting in order to straighten his penis in order to
have intercourse with a vacuum device. Seven patients
(54%) originally potent with oral phophodiesterase-5
inhibitors suffered from ED post-operatively. Possible
explanations for postoperative ED rates higher than
prior reports on grafting are: the large size of grafts
and number of grafts needed to correct severe (60-90
degree) curvatures, ventral position of plaque, our
surgical technique, and the graft itself (not precluding
venous leak). Preoperatively, one of the patients had
a ventral plaque, which has been shown to have the
greatest likelihood of postoperative venous leak (17).
The other 6 patients had curvatures of > 60 degrees,
with four having 90 degree bends. Additionally, five
of the patients required 2 grafts to repair the defect.
Importantly, the use of various instruments (e.g, International Index of Erectile Function, SHIM score,
SEP 2/3) among series to help assess ED may also
contribute to differences in reported ED rates, as these
instruments were not designed specifically for PD
patients.
Our findings with respect to postoperative ED
are similar to those of Leungwattanakij et al. who used
processed cadaveric pericardium instead of SIS. Five
out of 8 patients reported difficulty with erections due
to venous leakage at 30 months mean follow-up (18).
The authors postulated that patients with large plaque
size, ventral plaque, and severe curvatures (> 60)
may be more likely to have postoperative cavernosal
insufficiency leading to ED.
In our study, concomitant penile plication
was performed in 11 of 13 cases. In order to prevent
the need for plication in addition to the incision and

grafting procedure, we have since modified our surgical technique. The SIS graft is oversized by 130%
instead of 120%, and the H incision is broader and
larger. Moreover, we have started to excise a small,
linear segment of the plaque before placement of the
graft, a technique that other authors have found to
negate the need for a secondary plication (19).
Weaknesses of our study include a retrospective design, small sample size, and the use of
subjective assessments of satisfaction and erectile
function. Future studies on graft materials for the
surgical correction of PD should utilize objective
means of characterizing penile blood flow, such as
power Doppler ultrasonography of the penis, and
objective measures of rigidity and tumescence, such
as Rigiscan® nocturnal penile tumescence.

CONCLUSIONS
The results of our experience using SIS in
the repair of Peyronie’s disease demonstrate its efficacy in achieving a functional, straight erection with
durable results. The advantages of SIS include ease
of use and favorable biochemical characteristics as
well as ready availability and lack of need for native
tissue harvest with its attendant morbidity. Our study
showed a relatively higher rate of venous leak erectile
dysfunction than previously described, particularly
in men with greater penile curvature at baseline.
Larger studies investigating the true rates of erectile
dysfunction using SIS as well as comparisons with
other materials are warranted.
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EDITORIAL COMMENT
As authors described in this paper, surgical
approaches for the correction of PD can be divided
into three basic categories; tunical plication, plaque
excision (incision) and grafting procedures, and penile prosthesis implantation. Regarding to grafting
materials, saphenous vein grafts are the most widely
used with acceptable outcome in long-term. However,
ideal “off the shelf” biomaterial is warranted because
harvesting autologous material can cause the pain at
donor site and longer operative time. Various off-theshelf materials including SIS are currently reported
(1).
Authors reported on 13 patients with PD who
treated with SIS grafting. Seven patients (54%) had a
completely straight phallus and six (46%) had residual
bend less than 15 degree after 14-month follow-up.
Although only one patient had erectile dysfunction
preoperatively, 7 patients were impotent postoperatively. From these results, SIS grafts would allow for
satisfactory clinical results despite relatively high rate
of erectile dysfunction.

However, long-term outcome of surgery
for penile curvature is quite important to evaluate
the durability of the procedure and treatment strategies. Unfortunately, longer follow-up with adequate
number of patient treated with off-the-shelf material
are still lacking. Additionally, since it is recognized
that the majority of men with PD have vascular comorbidities that contribute to sexual dysfunction (2),
surgery is not an exclusive factor that causes postoperative erectile dysfunction. Better understanding of
the natural history of PD and long-term outcome of
each surgical procedure are still needed.
REFERENCES
1.

2.

Kadioglu A, Sanli O, Akman T, Ersay A, Guven S,
Mammadov F: Graft materials in Peyronie’s disease
surgery: a comprehensive review. J Sex Med. 2007;
4: 581-95.
Deveci S, Palese M, Parker M, Guhring P, Mulhall JP:
Erectile function profiles in men with Peyronie’s disease. J Urol. 2006; 175: 1807-11; discussion 1811.

Dr. Kimihiko Moriya

Department of Urology
Hokkaido University Graduate Sch of Med
Sapporo, Japan
E-mail: k-moriya@med.hokudai.ac.jp

197

